Tempus AI, Inc. (NASDAQ:TEM) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Tempus AI, Inc. (NASDAQ:TEM) has earned a consensus recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the company, MarketBeat.com reports. Two investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $48.67.

A number of equities analysts have recently issued reports on the company. Bank of America downgraded Tempus AI from a “buy” rating to a “neutral” rating and increased their price target for the stock from $45.00 to $60.00 in a research report on Wednesday, October 2nd. Loop Capital raised their target price on shares of Tempus AI from $48.00 to $57.00 and gave the company a “buy” rating in a research report on Tuesday, October 15th. Needham & Company LLC reaffirmed a “buy” rating and issued a $47.00 price target on shares of Tempus AI in a research report on Wednesday, August 7th. Piper Sandler started coverage on shares of Tempus AI in a report on Monday, August 12th. They set a “neutral” rating and a $40.00 price objective on the stock. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Tempus AI from $42.00 to $47.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 7th.

Institutional Trading of Tempus AI

Large investors have recently made changes to their positions in the business. First Horizon Advisors Inc. acquired a new stake in Tempus AI during the third quarter worth about $30,000. Sandia Investment Management LP purchased a new position in shares of Tempus AI during the 2nd quarter valued at approximately $136,000. Vestor Capital LLC purchased a new position in shares of Tempus AI during the 3rd quarter valued at approximately $153,000. IQ EQ FUND MANAGEMENT IRELAND Ltd purchased a new stake in Tempus AI during the third quarter worth $258,000. Finally, Clarus Group Inc. acquired a new stake in Tempus AI during the third quarter valued at $283,000.

Tempus AI Stock Performance

NASDAQ TEM opened at $73.77 on Monday. Tempus AI has a 12 month low of $22.89 and a 12 month high of $77.00. The business has a 50-day moving average of $50.22. The company has a current ratio of 2.69, a quick ratio of 3.52 and a debt-to-equity ratio of 8.17.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.